|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
ELV052590941 |
003 |
DE-627 |
005 |
20230624184823.0 |
007 |
cr uuu---uuuuu |
008 |
210910s2021 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.earlhumdev.2020.105285
|2 doi
|
028 |
5 |
2 |
|a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001265.pica
|
035 |
|
|
|a (DE-627)ELV052590941
|
035 |
|
|
|a (ELSEVIER)S0378-3782(20)30789-1
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
082 |
0 |
4 |
|a 610
|q VZ
|
082 |
0 |
4 |
|a 610
|q VZ
|
084 |
|
|
|a 44.45
|2 bkl
|
100 |
1 |
|
|a Tristão, Rosana M.
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Adaptation and validation of the EVENDOL scale to assess pain in neonates in Portuguese language
|
264 |
|
1 |
|c 2021
|
336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
520 |
|
|
|a EVENDOL scale (from the French Evaluation Enfant Douleur) is used to evaluate pain in children in any situation covering a wider age group than other pain scales (birth up to seven years). This study aimed to evaluate pain in hospitalized newborns, to adapt and validate the EVENDOL to Brazilian Portuguese.
|
700 |
1 |
|
|a Vilela, Laura R.
|4 oth
|
700 |
1 |
|
|a Marques, Luísa A.
|4 oth
|
700 |
1 |
|
|a Neiva, Elaine R.
|4 oth
|
700 |
1 |
|
|a Costa, Karina N.
|4 oth
|
700 |
1 |
|
|a de Jesus, José Alfredo L.
|4 oth
|
700 |
1 |
|
|a Fournier-Charrière, Elisabeth
|4 oth
|
773 |
0 |
8 |
|i Enthalten in
|n Elsevier Science
|a Abdel-Aziz, Tarek Ezzat ELSEVIER
|t Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics
|d 2014
|g Amsterdam [u.a.]
|w (DE-627)ELV022803173
|
773 |
1 |
8 |
|g volume:152
|g year:2021
|g pages:0
|
856 |
4 |
0 |
|u https://doi.org/10.1016/j.earlhumdev.2020.105285
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_U
|
912 |
|
|
|a GBV_ELV
|
912 |
|
|
|a SYSFLAG_U
|
912 |
|
|
|a SSG-OLC-PHA
|
912 |
|
|
|a GBV_ILN_130
|
912 |
|
|
|a GBV_ILN_350
|
936 |
b |
k |
|a 44.45
|j Immunologie
|q VZ
|
951 |
|
|
|a AR
|
952 |
|
|
|d 152
|j 2021
|h 0
|